Limitations of conventional doses of chemoradiation for unresectable biliary cancer. - Wikidata - awgldk - TriplyDB

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

http://www.wikidata.org/entity/Q34719557

about

Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution.Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma.Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.Early experience of helical tomotherapy for hepatobiliary radiotherapy Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials Management of hilar biliary strictures.Chemotherapy for cholangiocarcinoma: An update.Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism?Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.Positioning high-dose radiation in multidisciplinary management of unresectable cholangiocarcinomas: review of current evidence.Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma Salvage radiation therapy for isolated local recurrence of extrahepatic cholangiocarcinoma after radical surgery: a retrospective study.Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer.Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma.Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis.CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma.Dose escalation using helical tomotherapy improves local control in spine metastases from primary hepatic malignancies.Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma

P2860

Q24569648-27CEB7CB-F635-4B1F-91CF-C6A6C2854795 Q30148661-E30EB217-322B-4AD6-8C4A-9C4EE89F8F6C Q30440095-069A5997-A31D-435B-92F4-4A35D786796D Q31145431-E8F49ED2-EBF5-49C9-904F-EDD6479F8105 Q33435024-2ADE9DD0-7C8F-4EC6-B665-0495FDBE9E97 Q33692477-F2B43028-1707-4F45-A482-F190BAE6F481 Q34002121-51910032-AA30-4E94-9E1F-28B0D8CB416E Q34242523-7E8AE225-B727-4EEE-BC51-157759426276 Q34325467-4F942547-B7E7-4CA2-820E-78356C1F931C Q34596314-B7CA4B5F-7EE9-4957-8566-71F8B869E6E7 Q35110762-25DE13F8-69CD-49CA-9AFB-3C0311886451 Q35545055-24D0D49F-9F56-4794-B05F-4A1C61859E85 Q36190116-D9A88828-3B6E-44CB-BA5F-E1D41C5C4BBA Q36299709-7EF401AF-3471-4CC0-BFFE-6DDF27C61883 Q36755511-48057549-29FA-4B0B-A286-712185F97C61 Q36914411-EC72D9FB-E8CB-42BF-A921-DDB3AFA44EBF Q36984860-2304C820-4F92-47A3-B90F-B03BD5AFAAC0 Q37009026-57A1C537-2F03-4DB8-BFD2-BE17E056B004 Q37064558-9CA7F44B-B2FF-468A-8DE6-756A411E6AA3 Q37166422-4A857EF3-2455-4C53-80B4-7B92BD885875 Q37430354-D9A09C0B-36AB-420F-9557-62449BF83E78 Q37440707-659BEA85-B260-49F2-920E-2ED67F464E1B Q37522695-EE4344DD-F34E-41F2-85B3-4DCDE2875B7B Q37677527-9D046EA8-61AA-4586-8F39-9D23BACDCDFF Q37783933-BF6A2E2B-D410-4B2D-B2E3-530F3456A550 Q37817003-8D88C7FF-5A54-4156-9B01-272D1EF3F54A Q38241068-86048A88-9865-47AC-B485-CCE3D703AD22 Q41039645-F34F8411-5E45-4AB8-9FE3-DA73EDA9B625 Q42162594-65CB1732-A889-421B-9E3D-714C573CC321 Q45257647-ED25622A-BCB0-47C0-A441-151A5B6488A7 Q45363859-D0826FA0-6D21-4C7F-B3A0-1EC5ACAF624E Q47131872-E9181607-6C16-4875-8EF1-4A36ECEFCCB2 Q47137682-AC286C9E-BAF9-4504-8960-E5E405B760C4 Q47567014-2DFFDF3E-FBEF-4BFE-8730-EFABF3258422 Q49567454-56C3DBBE-9B99-426F-BDCB-720308243901 Q53101481-A0395CAE-0086-431E-AA79-43CB68022DCD Q58699994-1F805E11-F55F-4047-A237-34D83FE5FBC4

P2860

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

http://www.wikidata.org/entity/Q34719557

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@ast

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@en

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@nl

type

label

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@ast

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@en

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@nl

prefLabel

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@ast

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@en

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@nl

P1433

Q34719557-B5F8734E-B101-46B6-A2B7-9B82E73C8A66

P1476

Q34719557-CC4BA1BE-F3C2-4B65-884B-2879158B479E

P2093

Q34719557-18DBC2D7-99AE-4661-AE3F-65A20A414787

Q34719557-1ACE9B75-5B2A-4D8B-A459-09EF0C464B19

Q34719557-2AED2274-68C7-4BEF-8B64-531E102F0506

Q34719557-456E0941-3453-41E5-B44C-9929E7217F17

Q34719557-52C098D9-791E-48BE-983C-11A8128EE7C6

Q34719557-6D7E49B6-AE81-4171-93D5-99CD12DB73DD

Q34719557-7B0A33B1-0462-4506-8EAB-E2E909ACDF65

Q34719557-9FBF4717-A60E-46E2-A15F-BDCA726B0949

Q34719557-A2820A89-0FD5-4EB4-A4F5-8365EE37D36D

Q34719557-D6881CA4-862C-486D-991E-C0FFC69FD60C

P304

Q34719557-6B906F83-7CD9-48C9-8DE1-DDB82E6D7361

P31

Q34719557-9D882E72-29A4-40CF-BF87-7EA591F3D21F

P356

Q34719557-6AF6F473-350C-42A3-B3DF-F533E83671CD

P407

Q34719557-49374C83-ACE8-4BBC-B620-01963307B4A6

P433

Q34719557-E7C59011-4881-4893-9A58-FD9BB6A80CEC

P478

Q34719557-EB66DF8F-A54D-42C8-AA49-D1DBBEC7FDEC

P577

Q34719557-CB0B6849-802C-4646-B489-786D07207F77

P698

Q34719557-C08585E9-7D4E-4610-B3CC-D6E7083F3782

P921

Q34719557-65E6557F-ACE2-44A0-9E90-C80C23C90D8B

P356

S0360-3016(02)02845-6

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

@en

P2093

Adrian Wong

http://www.w3.org/2001/XMLSchema#string

Christopher H Crane

http://www.w3.org/2001/XMLSchema#string

Chusilp Charnsangavej

http://www.w3.org/2001/XMLSchema#string

J N Vauthey

http://www.w3.org/2001/XMLSchema#string

Kenneth O Macdonald

http://www.w3.org/2001/XMLSchema#string

Marc Delclos

http://www.w3.org/2001/XMLSchema#string

Nora A Janjan

http://www.w3.org/2001/XMLSchema#string

Patt Yehuda

http://www.w3.org/2001/XMLSchema#string

Steven Curley

http://www.w3.org/2001/XMLSchema#string

Thomas Brown

http://www.w3.org/2001/XMLSchema#string

P304

969-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0360-3016(02)02845-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12095564

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy